Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine. Lassauniere R, Polacek C, Linnea Tingstedt J, Fomsgaard A, et al. Vaccine 2023 Sep 17:S0264-410X(23)01091-5. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Lassauniere R, Polacek C, Linnea Tingstedt J, Fomsgaard A, et al. Preclinical evaluation of a SARS-CoV-2 variant B.1.351-based candidate DNA vaccine. Vaccine 2023 Sep 17:S0264-410X(23)01091-5. doi: 10.1016/j.vaccine.2023.
PMID: 37726179